Anne Wojcicki's TTAM Research Institute outbids Regeneron to acquire 23andMe assets for $305 million, reinforcing the company's founding vision. The nonprofit commits to strict privacy measures, including options for customers to delete genetic data and opt out of research. The deal awaits bankruptcy court approval, emphasizing enhanced protections around consumer genomic data.